Literature DB >> 687353

Protein phosphorylation in normal and neoplastic development. Phosphorylation of proteins endogenous to foetal tissues and tumours.

A M Malkinson, C E McSwigan.   

Abstract

The abilities of proteins endogenous to normal and neoplastic tissues to serve as substrates in a protein-phosphorylation reaction in vitro were compared. After the tissue extracts were incubated with [gamma-32P]ATP, the phosphorylated proteins were separated by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and the dried gels were subjected to radioautography. Considerable incorporation of 32P into a protein of mol.wt. 135000 was observed with extracts from foetal tissues and tumours, but only minimal incorporation into this protein occurred when extracts from adult tissues were used. The ability of this protein to become phosphorylated in vitro may be related to cell proliferation. When ascites cells were incubated with [32P]Pi, one of the major phosphoproteins migrated on sodium dodecyl suphate/polyacrylamide gels at mol.wt. 135000, suggesting that this protein can be phosphorylated both in intact cells and broken-cell preparations. A protein of mol.wt. 87000 was highly phosphorylatable in extracts from solid tumours, but was not phosphorylated in extracts from ascites tumours, foetal or adult tissues. The phosphorylation pattern of these two proteins can thus distinguish solid neoplasms and normal adult tissues from ascites tumours and from foetal tissues. A protein of mol.wt. 49000, which was the most labelled protein in adult tissues, was also one of the major phosphoproteins in foetal and neoplastic tissues. Numerous mechanisms are postulated to explain how the extent of 32P incorporation into a protein could vary as a function of biological state.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 687353      PMCID: PMC1185716          DOI: 10.1042/bj1720423

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Developmental changes in the cyclic AMP-dependent phosphorylation and dephosphorylation of a protein endogenous to murine brain and liver.

Authors:  A M Malkinson
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Density-dependent phosphorylation of a specific protein in cultured cells.

Authors:  J M Wehner; J R Sheppard; A M Malkinson
Journal:  Nature       Date:  1977-04-28       Impact factor: 49.962

Review 4.  Role of cyclic nucleotides in cancer.

Authors:  W L Ryan; M L Heidrick
Journal:  Adv Cyclic Nucleotide Res       Date:  1974

5.  Phosphorylation of a cyclic adenosine 3':5'-monophosphate-dependent protein kinase from bovine cardiac muscle.

Authors:  J Erlichman; R Rosenfeld; O M Rosen
Journal:  J Biol Chem       Date:  1974-08-10       Impact factor: 5.157

6.  Regulation of adenosine 3',5'-monophosphate-dependent protein kinase. II. Hormonal regulation of the adipose tissue enzyme.

Authors:  T R Soderling; J D Corbin; C R Park
Journal:  J Biol Chem       Date:  1973-03-10       Impact factor: 5.157

7.  ATP(Mg 2+ ) induced inhibition of cyclic AMP reactivity with a skeletal muscle protein kinase.

Authors:  M K Haddox; N E Newton; D K Hartle; N D Goldberg
Journal:  Biochem Biophys Res Commun       Date:  1972-05-26       Impact factor: 3.575

8.  Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom.

Authors:  J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

9.  Comparison of nuclear nonhistone phosphoproteins of rat liver and Novikoff hepatoma.

Authors:  N Ganpath; A W Prestayko; H Busch
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

10.  The phosphorylation of histones in rat liver undergoing malignant transformation.

Authors:  K Letnansky; J Wenzel
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.